NKTR EPS Estimates
Nektar Therapeutics
$36.89
-$1.03(-2.72%)
30
Overall
40
Value
9
Tech
42
Quality
Market Cap
$1.26B
Volume
999.60K
52W Range
$33.40 - $109.00
Target Price
$132.73
NKTR EPS estimates: the consensus estimate for Nektar Therapeutics's current fiscal year is -$8.16 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NKTR EPS Estimates
- EPS estimate, current quarter
- $-2.20
- EPS estimate, next quarter
- $-2.80
- EPS estimate, current year
- $-8.16
- EPS estimate, next year
- $-10.99
- EPS growth, 3-year
- +30.95%
| Fiscal year | EPS |
|---|---|
| 2025 | $-9.73 |
| 2024 | $-8.70 |
| 2023 | $-21.75 |
| 2022 | $-29.55 |
| 2021 | $-42.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $36.89 | -2.7% | 999.60K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |